Baseline IGF-I levels determine insulin secretion and insulin sensitivity during the first year on growth hormone therapy in children born small for gestational age. Results from a North European Multicentre Study (NESGAS).
about
Baseline IGF-I levels determine insulin secretion and insulin sensitivity during the first year on growth hormone therapy in children born small for gestational age. Results from a North European Multicentre Study (NESGAS).
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Baseline IGF-I levels determin ...... an Multicentre Study (NESGAS).
@en
Baseline IGF-I levels determin ...... rth European Multicentre Study
@nl
type
label
Baseline IGF-I levels determin ...... an Multicentre Study (NESGAS).
@en
Baseline IGF-I levels determin ...... rth European Multicentre Study
@nl
prefLabel
Baseline IGF-I levels determin ...... an Multicentre Study (NESGAS).
@en
Baseline IGF-I levels determin ...... rth European Multicentre Study
@nl
P2093
P50
P356
P1433
P1476
Baseline IGF-I levels determin ...... an Multicentre Study (NESGAS).
@en
P2093
Burak Salgin
Hilary Hoey
Jeremy Kirk
Malcolm Donaldson
NESGAS Group
Olle Söder
Rikke Beck Jensen
Sten-A Ivarsson
Susan M O'Connell
P356
10.1159/000353438
P577
2013-07-13T00:00:00Z